Some providers featured on this site may compensate us. This may affect the order and placement of listings but does not influence our editorial ratings or reviews.
Treatments Hub

Verified prices

All verified prices
Advice7 min read

Best Mounjaro Alternatives for Weight Loss in 2026

Looking for Mounjaro alternatives? Compare compounded tirzepatide, semaglutide options, and the top telehealth providers offering affordable GLP-1 treatment.

Updated September 15, 2026

Medically reviewed on

How we review

The quick answerThe closest Mounjaro alternatives are compounded tirzepatide plans - the same active ingredient - from licensed telehealth providers: $71/month at welludr, $99 at embody, $147 at DirectMeds, versus roughly $1,000+ for brand-name. Prescription required, shipped to your door.Prices verified on each provider’s site as of November 3, 2026.

Why People Look for Mounjaro Alternatives

Mounjaro (tirzepatide) has shown the best weight loss results of any GLP-1 medication, but at $1,000-$1,100/month retail, it's expensive. Insurance coverage for weight loss use is limited.

Some patients also want to try semaglutide first at a lower price point before moving to tirzepatide. Here are the best alternatives.

Our top-rated GLP-1 providers

Our recommended telehealth providers - the same cards from our full comparison.

Our Top Pick
1
embody logo

Exceptional

9.8out of 10

Compounded GLP-1 from $49/month; not FDA-approved, free expedited delivery

Free expedited deliveryNo hidden fees
  • Compounded semaglutide ($49/mo) and tirzepatide ($99/mo) as shown on the homepage, Nov 16, 2026; not FDA-approved
  • Online intake, then a prescriber review by OpenLoop Health, a network of US-licensed doctors
  • Free expedited delivery (embody's words); the Terms do not guarantee a delivery timeline
  • No insurance required, no clinic visits; cancel at least 72 hours before the next billing date

from $49/month

Doctor-prescribed compounded GLP-1 treatment, not FDA-approved: semaglutide shown at $49/month and tirzepatide at $99/month on embody's homepage (Nov 16, 2026), no insurance required.

Read full embody review
2
altRx logo

Excellent

9.4out of 10

Most Comprehensive GLP-1 Medication Access

Transparent pricingNo insurance required
  • Compounded GLP-1 from $89/mo, GLP-1 + GIP from $149/mo
  • Brand-name options too: Zepbound and Wegovy
  • Clinician-guided - physician, PA, or nurse practitioner
  • Free shipping (about 5-7 days)

from $89/month

Affordable GLP-1 program from $89/month - compounded semaglutide and tirzepatide plus brand-name options - with clinician-guided, self-pay care and no insurance required.

Read full altRx review
3
TrimRx logo

Very Good

8.9out of 10

Limited time offer - $140 off all weight loss plans

HIPAA compliantMade in USA
  • Compounded semaglutide $149/month - same price at every dose
  • Compounded tirzepatide $259/month
  • Custom dosing with unlimited provider check-ins
  • Free consultation and free tracked delivery - often next-day

from $149/month

Telehealth GLP-1 program built around custom dosing and unlimited provider check-ins - compounded semaglutide $149/month, the same at every dose, and tirzepatide $259/month.

Read full TrimRx review

Compounded Tirzepatide - Same Ingredient, Lower Cost

The most direct Mounjaro alternative is compounded tirzepatide - same active ingredient at $300-$500/month through telehealth providers. Several providers offer compounded tirzepatide including altRx. See our tirzepatide providers page for a full comparison.

Zepbound - The Weight-Loss Approved Version

Zepbound is tirzepatide specifically FDA-approved for weight loss (Mounjaro is approved for diabetes). Same medication, same results, but purpose-built for weight management.

Pricing is similar to Mounjaro at retail. See our Zepbound vs Wegovy comparison.

Shop tirzepatide plans by provider

Published tirzepatide plans - cheapest first, conditions under each price.

Semaglutide - The Budget Alternative

If cost is your primary concern, compounded semaglutide starts at just $199/month - significantly less than tirzepatide. While semaglutide produces slightly less weight loss on average (15% vs 22%), it's still highly effective and more affordable.

Many patients start with semaglutide and switch to tirzepatide later if needed. See our Mounjaro vs Ozempic comparison.

What To Know Before Starting GLP-1 Treatment

Before starting GLP-1 treatment, it's important to understand a few key things. These medications require a prescription from a licensed clinician and aren't suitable for everyone. Some people may experience side effects, especially during the first few weeks as the body adjusts.

GLP-1s also tend to work best when combined with basic lifestyle habits like balanced nutrition and regular physical activity.

That's why choosing a provider that offers proper medical screening and ongoing follow-up support is essential for both safety and long-term success.

Woman preparing GLP-1 weight loss injection

Top Providers for Mounjaro Alternatives

altRx offers both compounded semaglutide and tirzepatide. TrimRx offers affordable compounded GLP-1 options. SHED provides personalized treatment plans with multiple medication pathways. All include physician oversight and home delivery.

How to Choose

Want the same tirzepatide at lower cost? Compounded tirzepatide through telehealth.

Want to save even more? Start with compounded semaglutide ($199/month).

Want the FDA weight-loss approved version? Ask about Zepbound. Take our quiz to find the best provider for your goals and budget, or compare all providers.

Ready to compare weight loss providers?

See how top providers stack up on pricing, medical support, and treatment options.

Medical disclaimer

This page is general information about GLP-1 weight-loss medications such as semaglutide and tirzepatide, published to help you compare services. It is not medical advice, it does not create a doctor-patient relationship, and it is not a substitute for a consultation with a licensed clinician who knows your history. Treatments Hub is not a medical provider, pharmacy or clinic and does not prescribe, sell or dispense medication. Do not start, stop or change any treatment because of something you read here, and do not delay seeking care; in an emergency call 911.

Semaglutide and tirzepatide carry an FDA boxed warning about thyroid C-cell tumours seen in rodents and are not for anyone with a personal or family history of medullary thyroid carcinoma or MEN 2, nor for use in pregnancy. Compounded versions sold by telehealth providers are prepared by state-licensed pharmacies and are not FDA-approved products. Where a review or post on this page mentions weight lost, that is one person's result and is not typical; results vary widely.

Medical and scientific statements on this site are checked against the sources linked on the page by our medical content reviewer, who does not choose providers or set prices. Prices, plans and customer reviews are each provider's published figures and customers' own words on the dates stated. We may earn a commission from provider links. The full medical and advertising disclaimer explains all of this in detail.

Sources & medical references

Treatment facts on this page are grounded in regulatory guidance and peer-reviewed research. Pricing and plan details come from each provider's published information. This content is for information only and is not medical advice - always consult a licensed clinician before starting treatment.

  1. 1.Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1 trial) - New England Journal of Medicine, 2021
  2. 2.Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1 trial) - New England Journal of Medicine, 2022
  3. 3.FDA Approves New Drug Treatment for Chronic Weight Management (semaglutide / Wegovy) - U.S. Food & Drug Administration, 2021
  4. 4.FDA Approves New Medication for Chronic Weight Management (tirzepatide / Zepbound) - U.S. Food & Drug Administration, 2023
  5. 5.FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss - U.S. Food & Drug Administration
  6. 6.Human Drug Compounding (503A pharmacy standards) - U.S. Food & Drug Administration
  7. 7.Semaglutide Injection - drug information - MedlinePlus, U.S. National Library of Medicine (NIH)